Array BioPharma Inc (NASDAQ:ARRY) looks like an inverse head-and-shoulders, and a breakout on Wednesday that took it up 1.16, or 7.7%, to 16.20, on 6 million shares. That’s the biggest volume since May when it broke out. I’m looking for that to extend as well. The targets are 18 and 20, and eventually 23 1/2-3/4.
Caredx Inc (NASDAQ:CDNA) popped out on Wednesday, gaining 1.56, or 6.35%, to 26.11, on nearly a million shares, pulled back, reached a little bit of resistance, and I’m not surprised it did so. The key is 29 1/2. If it gets through that, I’m looking at a stock in the high 30’s and 40’s.
FireEye Inc (NASDAQ:FEYE) has had a nice base over the last three years, and finally punched through it on Wednesday, popping 1.64, or 10%, to 18.49, on 18 million shares. At this point, I’m looking for 19.35-6 at resistance. If it gets through that, it may see 22 and 24.
Tandem Diabetes Care Inc (NASDAQ:TNDM) was up 2.92, or 8.4%, to 37.61, on 2 million shares on Wednesday. It broke a declining topsline with a reversal bar and appears that some resistance remains at 37.70. If it gets through minor resistance at 30.40, we’re looking at 37 1/2 and 40 1/2 as targets going forward.
Stocks on the long side included Aerojet Rocketdyne Holdings, Inc. (AJRD), Accuray Incorporated (ARAY), Array BioPharma Inc. (ARRY), Bandwidth Inc. (BAND), BioTelemetry, Inc. (BEAT), CareDx, Inc (CDNA), Denny's Corporation (DENN), FireEye, Inc. (FEYE), Globus Maritime Limited (GLBS), Kindred Biosciences, Inc. (KIN), NeoGenomics, Inc. (NEO), QuinStreet, Inc. (QNST), Strongbridge Biopharma plc (SBBP), Seaspan Corporation (SSW), TAL Education Group (TAL), Molson Coors Brewing Company (NYSE:TAP), Tandem Diabetes Care, Inc. (TNDM), Twilio Inc. (TWLO), Veracyte, Inc. (VCYT), 21Vianet Group, Inc. (VNET), and Xilinx, Inc. (NASDAQ:XLNX).
Watch video here.